paclitaxel has been researched along with Arterial Occlusive Diseases in 52 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 15 (28.85) | 29.6817 |
| 2010's | 33 (63.46) | 24.3611 |
| 2020's | 4 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, K; Li, L; Zhao, S | 1 |
| Arakawa, M; Hayakawa, N; Hirano, S; Ichihara, S; Inoguchi, Y; Kanagami, T; Kanda, J; Kodera, S; Shakya, S; Takanashi, K | 1 |
| Beelen, R; Bosiers, M; Callaert, J; Deloose, K; Hendriks, J; Keirse, K; Maene, L; Scheinert, D; Torsello, G; van den Eynde, W; Verbist, J; Wauters, J | 1 |
| Holden, A; Schermerhorn, M; Schneider, PA; Secemsky, E; Varcoe, RL | 1 |
| Klumb, C; Teichgräber, UK | 1 |
| Albrecht, T; Kutschera, M; Meyer, DR; Speck, U; Tepe, G; Ukrow, A; Waliszewski, M; Werk, M; Zeller, T | 1 |
| Camacho-Freire, SJ; Cardenal-Piris, R; Díaz-Fernández, JF; El Amrawy, AM; León-Jiménez, J | 1 |
| Ansel, GM; Brodmann, M; Doros, G; Elmariah, S; Fuller, S; Gray, WA; Mauri, L; Pinto, DS; Rosenfield, KA | 1 |
| Beschorner, U; Böhme, T; Mpj Reijnen, M; Noory, E; Zeller, T | 1 |
| Bi, W; Du, X; Fu, WG; Guo, PF; Guo, W; Jia, X; Wang, F; Wang, SM; Wu, DM; Zhang, JW; Zhang, MH; Zhao, Y; Zhuang, BX | 1 |
| de Boer, SW; de Vries, JP; Elgersma, O; Fioole, B; Heyligers, JM; Karimi, A; Lohle, PN; Nolthenius, RP; van den Heuvel, DA; Vos, JA; Vroegindeweij, D | 1 |
| Afari, ME; Buszman, PP; Conditt, GB; Granada, JF; Kaluza, GL; McGregor, JC; Peppas, A; Rousselle, SD; Stenoien, M; Tellez, A | 1 |
| Günther, RW; Kelm, M; Krombach, GA; Neizel, M; Ruebben, A; Weiss, N | 1 |
| Bagdat'ev, VE; Dzhurakulov, ShR; Shipovskiĭ, VN; Tursunov, SB; Zatevakhin, II | 1 |
| Pityk, AI | 1 |
| Cannavale, A; Fanelli, F | 1 |
| Werk, M | 1 |
| Ansel, GM; Dake, MD; Jaff, MR; Machan, LS; O'Leary, EE; Ohki, T; Ragheb, AO; Saxon, RR; Smouse, HB; Snyder, SA; Zeller, T | 1 |
| Kret, MR; Lee, JT; Tran, K; Ullery, BW | 1 |
| Bague, N; Cardon, JM; Chatelard, P; Commeau, P; Garbé, JF; Gouëffic, Y; Guyomarch, B; Julia, P; Penillon, S; Pernès, JM; Planché, O; Sauguet, A | 1 |
| Minar, E; Schillinger, M | 2 |
| Baumgartner, I; Diehm, N; Jüni, P | 1 |
| Hennebry, TA; Latif, F | 1 |
| Briguori, C; Taranto, D; Visconti, G | 1 |
| de Vries, JP; Hansen, BE; Knippenberg, B; Martens, JM; van Overhagen, H; Vos, JA | 1 |
| Forbes, TL | 1 |
| Chavan, A; Luthe, L; Schmuck, B | 1 |
| Cester, G; Manzi, M; Palena, LM | 1 |
| Gomes, M; Groffsky, JL; Leville, CD; Long, TD; McMillan, WD; Schultz, SR | 1 |
| Freyhardt, P; Kröncke, TJ; Rastan, A; Schreiter, NF; Schwarzwaelder, U; Sixt, S; Stiepani, H; Werk, M; Zeller, T | 1 |
| Scheller, B; Schnorr, B; Speck, U | 1 |
| Bosiers, M; Dake, MD; Fanelli, F; Kavteladze, Z; Lottes, AE; Ragheb, AO; Ruhlmann, C; Scheinert, D; Tepe, G; Tessarek, J; Zeller, T | 1 |
| Biamino, G; Castriota, F; Cioppa, A; Cremonesi, A; Grattoni, C; Marchese, A; Micari, A; Pantaleo, P; Rubino, P; Stabile, E; Vadalà, G | 1 |
| Scheinert, D | 1 |
| Biamino, G; Castriota, F; Cioppa, A; Cremonesi, A; Grattoni, C; Liso, A; Marchese, A; Micari, A; Pantaleo, P; Rubino, P; Vadalà, G | 1 |
| Biondi-Zoccai, G; Centola, M; Ferraresi, R | 1 |
| Ju, MH; Rodríguez, HE | 1 |
| Katsanos, K; Krokidis, M; Sabharwal, T; Spiliopoulos, S | 1 |
| Boatta, E; Cannavale, A; Cirelli, C; Corona, M; Fanelli, F; Lucatelli, P; Salvatori, FM; Wlderk, A | 1 |
| Varcoe, RL | 1 |
| De Cock, E; de Lissovoy, G; Julia, P; Lopes, S; Sapoval, M | 1 |
| Ahmed, MN; Albrecht, T; Behne, A; Dietz, U; Eschenbach, G; Hänninen, EL; Hartmann, H; Lange, C; Meyer, DR; Schnorr, B; Stiepani, H; Werk, M; Zoccai, GB | 1 |
| Amabile, PG; Boroumand, S; Celletti, FL; Dake, MD; Kao, EY; Waugh, JM | 1 |
| Duda, SH; Haase, KK; Poerner, TC; Rundback, JH; Tepe, G; Wiesinger, B; Wiskirchen, J | 1 |
| Belardi, J; Bilodeau, L; Chan, C; Colombo, A; Dawkins, K; Degertekin, M; Disco, C; Grube, E; Guagliumi, G; Kelbaek, H; Koglin, J; Munzel, T; Ormiston, J; Roy, L; Russell, ME; Ruzyllo, W; Serruys, PW; Strauss, BH; Tanabe, K | 1 |
| Valdés Chávarri, M | 1 |
| Machan, L | 1 |
| Tepe, G | 1 |
| Bhambi, B; Sharma, S | 1 |
| Morrissey, NJ | 1 |
| Albrecht, T; Beregi, JP; Claussen, CD; Heller, S; Oldenburg, A; Scheller, B; Schwarzwälder, U; Speck, U; Tepe, G; Zeller, T | 1 |
16 review(s) available for paclitaxel and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Network Analysis of Endovascular Treatment Strategies for Femoropopliteal Arterial Occlusive Disease.
Topics: Arterial Occlusive Diseases; Bayes Theorem; Femoral Artery; Humans; Paclitaxel; Peripheral Arterial Disease; Popliteal Artery; Sirolimus; Stents; Treatment Outcome; Vascular Patency | 2023 |
Update on paclitaxel for femoral-popliteal occlusive disease in the 15 months following a summary level meta-analysis demonstrated increased risk of late mortality and dose response to paclitaxel.
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Coated Materials, Biocompatible; Dose-Response Relationship, Drug; Femoral Artery; Follow-Up Studies; Global Health; Humans; Paclitaxel; Popliteal Artery; Survival Rate; Time Factors; Tubulin Modulators | 2021 |
[Drug-coated Balloon Angioplasty in Femoropopliteal Arteries - Is There a Class Effect?]
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Equipment Design; Humans; Paclitaxel | 2017 |
Drug coated balloons below-the-knee: just too early?
Topics: Angioplasty, Balloon; Antineoplastic Agents, Phytogenic; Arterial Occlusive Diseases; Coated Materials, Biocompatible; Drug Delivery Systems; Drug-Eluting Stents; Endovascular Procedures; Equipment Design; Humans; Leg; Paclitaxel; Peripheral Vascular Diseases; Popliteal Artery; Surface Properties; Treatment Failure | 2016 |
What are the potential limitations of drug coated balloons and possible ways to overcome.
Topics: Angioplasty, Balloon; Antineoplastic Agents, Phytogenic; Arterial Occlusive Diseases; Coated Materials, Biocompatible; Drug Delivery Systems; Drug-Eluting Stents; Endovascular Procedures; Equipment Design; Femoral Artery; Humans; Leg; Paclitaxel; Peripheral Vascular Diseases; Surface Properties | 2016 |
[Peripheral vascular disease of iliac and femoro-popliteal arteries: state-of-the-art endoluminal revascularization].
Topics: Angiography; Angioplasty, Balloon; Antineoplastic Agents, Phytogenic; Arterial Occlusive Diseases; Calcinosis; Drug-Eluting Stents; Femoral Artery; Humans; Iliac Artery; Ischemia; Leg; Paclitaxel; Popliteal Artery; Secondary Prevention; Stents | 2010 |
Paclitaxel-coated balloon angioplasty for lower extremity revascularization: a new way to fight in-stent restenosis.
Topics: Angioplasty, Balloon; Animals; Arterial Occlusive Diseases; Cardiovascular Agents; Constriction, Pathologic; Drug-Eluting Stents; Evidence-Based Medicine; Humans; Lower Extremity; Paclitaxel; Prosthesis Design; Secondary Prevention; Treatment Outcome | 2010 |
Review of clinical data with Paccocath- coated balloon catheters.
Topics: Arterial Occlusive Diseases; Catheterization; Constriction, Pathologic; Coronary Stenosis; Equipment Design; Humans; Paclitaxel | 2011 |
Advances in below-the-knee drug-eluting balloons.
Topics: Angioplasty, Balloon; Antineoplastic Agents, Phytogenic; Arterial Occlusive Diseases; Drug-Eluting Stents; Humans; Leg; Paclitaxel; Popliteal Artery; Prosthesis Design; Treatment Outcome | 2012 |
Standard balloon angioplasty versus angioplasty with paclitaxel-eluting balloons for femoropopliteal artery stenosis.
Topics: Angioplasty, Balloon; Animals; Arterial Occlusive Diseases; Cardiovascular Agents; Coated Materials, Biocompatible; Constriction, Pathologic; Drug-Eluting Stents; Femoral Artery; Humans; Paclitaxel; Popliteal Artery; Treatment Outcome | 2012 |
Innovative technologies for SFA occlusions: drug coated balloons in SFA lesions.
Topics: Angioplasty, Balloon; Animals; Arterial Occlusive Diseases; Cardiovascular Agents; Catheters; Coated Materials, Biocompatible; Constriction, Pathologic; Equipment Design; Female; Femoral Artery; Humans; Male; Middle Aged; Paclitaxel; Radiography; Recurrence; Treatment Outcome; Vascular Patency | 2012 |
Peripheral applications of drug-coated balloons: past, present and future.
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Coated Materials, Biocompatible; Drug-Eluting Stents; Humans; Paclitaxel; Peripheral Vascular Diseases; Prosthesis Design; Randomized Controlled Trials as Topic | 2013 |
Drug-eluting stents: potential applications for peripheral arterial occlusive disease.
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents; Arterial Occlusive Diseases; Coronary Restenosis; Dexamethasone; Drug Delivery Systems; Humans; Immunosuppressive Agents; Paclitaxel; Prosthesis Design; Recurrence; Sirolimus; Stents; Vascular Patency | 2003 |
[Is systematic use of drug-eluting stents justified? Arguments in favour].
Topics: Arterial Occlusive Diseases; Clinical Trials as Topic; Combined Modality Therapy; Coronary Stenosis; Drug Delivery Systems; Humans; Paclitaxel; Sirolimus; Stents | 2004 |
Drug eluting stents in the infrainguinal circulation.
Topics: Animals; Arterial Occlusive Diseases; Femoral Artery; Humans; Hyperplasia; Paclitaxel; Popliteal Artery; Radiography; Recurrence; Sirolimus; Stents; Tunica Intima; Vascular Patency | 2004 |
Drug-eluting stents for infrainguinal occlusive disease: progress and challenges.
Topics: Arterial Occlusive Diseases; Cardiovascular Agents; Drug Delivery Systems; Femoral Artery; Humans; Paclitaxel; Secondary Prevention; Sirolimus; Stents | 2006 |
11 trial(s) available for paclitaxel and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Impact of Patient and Lesion Characteristics on Drug-Coated Balloon Angioplasty in the Femoropopliteal Artery: A Pooled Analysis of Four Randomized Controlled Multicenter Trials.
Topics: Age Factors; Aged; Angiography, Digital Subtraction; Angioplasty, Balloon; Arterial Occlusive Diseases; Coated Materials, Biocompatible; Female; Femoral Artery; Health Status; Humans; Male; Paclitaxel; Popliteal Artery; Prospective Studies; Sex Factors; Time Factors; Treatment Outcome; Tubulin Modulators | 2019 |
Design and rationale of a randomized noninferiority trial to evaluate the SurVeil drug-coated balloon in subjects with stenotic lesions of the femoropopliteal artery - the TRANSCEND study.
Topics: Aged; Angiography; Angioplasty, Balloon; Arterial Occlusive Diseases; Coated Materials, Biocompatible; Equipment Design; Female; Femoral Artery; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Popliteal Artery; Prospective Studies; Single-Blind Method; Time Factors; Treatment Outcome; Vascular Patency | 2019 |
Randomized trial of Legflow(®) paclitaxel eluting balloon and stenting versus standard percutaneous transluminal angioplasty and stenting for the treatment of intermediate and long lesions of the superficial femoral artery (RAPID trial): study protocol fo
Topics: Alloys; Amputation, Surgical; Angiography, Digital Subtraction; Angioplasty, Balloon; Ankle Brachial Index; Arterial Occlusive Diseases; Cardiovascular Agents; Clinical Protocols; Coated Materials, Biocompatible; Constriction, Pathologic; Equipment Design; Equipment Failure; Femoral Artery; Hemodynamics; Humans; Hyperplasia; Limb Salvage; Neointima; Netherlands; Paclitaxel; Predictive Value of Tests; Prosthesis Design; Prosthesis Failure; Recurrence; Research Design; Resins, Plant; Single-Blind Method; Stents; Surveys and Questionnaires; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Duplex; Vascular Access Devices | 2013 |
Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial.
Topics: Adult; Aged; Angioplasty; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Drug-Eluting Stents; Equipment Failure; Female; Femoral Artery; Follow-Up Studies; Humans; Intermittent Claudication; Ischemia; Male; Middle Aged; Paclitaxel; Popliteal Artery; Recurrence; Stents; Ticlopidine; Vascular Patency | 2016 |
Femoropopliteal In-stent Restenosis Repair: Midterm Outcomes After Paclitaxel Eluting Balloon Use (PLAISIR Trial).
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon; Arterial Occlusive Diseases; Female; Femoral Artery; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Popliteal Artery; Prospective Studies; Recurrence; Reoperation; Treatment Outcome | 2017 |
Update on PADI trial: percutaneous transluminal angioplasty and drug-eluting stents for infrapopliteal lesions in critical limb ischemia.
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Cardiovascular Agents; Constriction, Pathologic; Critical Illness; Drug-Eluting Stents; Humans; Ischemia; Lower Extremity; Metals; Netherlands; Paclitaxel; Popliteal Artery; Prospective Studies; Prosthesis Design; Research Design; Secondary Prevention; Stents; Treatment Outcome | 2009 |
Plasma levels following application of paclitaxel-coated balloon catheters in patients with stenotic or occluded femoropopliteal arteries.
Topics: Aged; Antineoplastic Agents, Phytogenic; Arterial Occlusive Diseases; Biological Availability; Catheterization; Coated Materials, Biocompatible; Dose-Response Relationship, Drug; Drug Delivery Systems; Equipment Safety; Female; Femoral Artery; Humans; Male; Metabolic Clearance Rate; Middle Aged; Paclitaxel; Popliteal Artery | 2011 |
Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Angioplasty, Balloon; Arterial Occlusive Diseases; Cardiovascular Agents; Constriction, Pathologic; Drug Carriers; Equipment Design; Female; Femoral Artery; Humans; Limb Salvage; Lower Extremity; Male; Middle Aged; Paclitaxel; Popliteal Artery; Prospective Studies; Radiography; Recurrence; Rome; Severity of Illness Index; Stents; Thrombosis; Time Factors; Treatment Outcome; Vascular Access Devices | 2012 |
Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Angioplasty, Balloon; Arterial Occlusive Diseases; Cardiovascular Agents; Chi-Square Distribution; Coated Materials, Biocompatible; Constriction, Pathologic; Drug Carriers; Equipment Design; Female; Femoral Artery; Germany; Humans; Kaplan-Meier Estimate; Likelihood Functions; Linear Models; Male; Middle Aged; Paclitaxel; Popliteal Artery; Proportional Hazards Models; Radiography; Secondary Prevention; Time Factors; Treatment Outcome; Vascular Access Devices | 2012 |
Chronic arterial responses to polymer-controlled paclitaxel-eluting stents: comparison with bare metal stents by serial intravascular ultrasound analyses: data from the randomized TAXUS-II trial.
Topics: Angioplasty; Arterial Occlusive Diseases; Arteries; Double-Blind Method; Female; Follow-Up Studies; Humans; Hyperplasia; Male; Metals; Middle Aged; Paclitaxel; Polymers; Stents; Tunica Intima; Ultrasonography | 2004 |
Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon; Arterial Occlusive Diseases; Contrast Media; Female; Femoral Artery; Follow-Up Studies; Humans; Leg; Male; Middle Aged; Paclitaxel; Popliteal Artery; Radiography; Secondary Prevention; Statistics, Nonparametric; Treatment Outcome | 2008 |
25 other study(ies) available for paclitaxel and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Optimal Intraluminal Drug-Coated Balloon Versus Drug-Eluting Stent in Patients With Chronic Total Occlusion of the Superficial Femoral Artery: A Retrospective Analysis.
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Coated Materials, Biocompatible; Drug-Eluting Stents; Femoral Artery; Humans; Paclitaxel; Peripheral Arterial Disease; Popliteal Artery; Retrospective Studies; Treatment Outcome; Vascular Patency | 2022 |
One-year outcome of the paclitaxel-eluting Legflow balloon catheter in the treatment of long and complex femoropopliteal lesions.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Angioplasty, Balloon; Arterial Occlusive Diseases; Drug-Eluting Stents; Female; Femoral Artery; Humans; Male; Middle Aged; Paclitaxel; Popliteal Artery; Prospective Studies; Vascular Patency | 2020 |
Long term efficacy of drug coated balloon for radial artery angioplasty.
Topics: Aged; Angiography; Angioplasty, Balloon; Antineoplastic Agents, Phytogenic; Arterial Occlusive Diseases; Coated Materials, Biocompatible; Equipment Design; Follow-Up Studies; Humans; Male; Paclitaxel; Radial Artery; Time Factors; Vascular Calcification | 2018 |
Outstanding effectiveness of paclitaxel-based technologies for the treatment of femoropopliteal artery occlusive disease on the potential expense of increased late all-cause mortality? No reason to panic.
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Femoral Artery; Humans; Paclitaxel; Popliteal Artery; Treatment Outcome; Vascular Patency | 2019 |
Comparison between paclitaxel-coated balloon and standard uncoated balloon in the treatment of femoropopliteal long lesions in diabetics.
Topics: Aged; Angiography; Angioplasty; Angioplasty, Balloon; Antineoplastic Agents, Phytogenic; Arterial Occlusive Diseases; Atherosclerosis; Coated Materials, Biocompatible; Diabetes Complications; Diabetes Mellitus; Female; Femoral Artery; Humans; Male; Middle Aged; Paclitaxel; Peripheral Arterial Disease; Popliteal Artery; Treatment Outcome | 2019 |
Tissue uptake, distribution, and healing response after delivery of paclitaxel via second-generation iopromide-based balloon coating: a comparison with the first-generation technology in the iliofemoral porcine model.
Topics: Angioplasty, Balloon; Animals; Arterial Occlusive Diseases; Cardiovascular Agents; Cell Proliferation; Coated Materials, Biocompatible; Constriction, Pathologic; Contrast Media; Disease Models, Animal; Equipment Design; Femoral Artery; Fibrosis; Hyperlipoproteinemia Type II; Iliac Artery; Iohexol; Neointima; Paclitaxel; Radiography; Sus scrofa; Tissue Distribution; Vascular Access Devices; Wound Healing | 2013 |
Monitoring of gadolinium-BOPTA uptake into the vessel wall during magnetic resonance (MR)-guided angioplasty of the peripheral arteries with a paclitaxel/gadolinium-BOPTA-coated balloon: an experimental study at 3 Tesla.
Topics: Angioplasty, Balloon; Animals; Arterial Occlusive Diseases; Contrast Media; Drug Monitoring; Drug-Eluting Stents; Iliac Artery; Magnetic Resonance Angiography; Meglumine; Organometallic Compounds; Paclitaxel; Peripheral Arterial Disease; Surgery, Computer-Assisted; Swine | 2014 |
[Remote results of angioplasty using drug-coated balloons in lesions of the femoropopliteal segment].
Topics: Adult; Aged; Aged, 80 and over; Angiography; Angioplasty, Balloon; Antineoplastic Agents, Phytogenic; Arterial Occlusive Diseases; Equipment Design; Female; Femoral Artery; Follow-Up Studies; Humans; Ischemia; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Popliteal Artery; Russia; Severity of Illness Index; Treatment Outcome; Vascular Patency | 2014 |
[Efficacy of balloon catheters with antiproliferative cover in patients with impairment of arteries of femoral-popliteal segment].
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Coated Materials, Biocompatible; Constriction, Pathologic; Cytostatic Agents; Femoral Artery; Humans; Paclitaxel; Popliteal Artery; Recurrence; Treatment Outcome; Vascular Access Devices | 2015 |
Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
Topics: Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Cardiovascular Agents; Constriction, Pathologic; Critical Illness; Disease-Free Survival; Drug-Eluting Stents; Endovascular Procedures; Female; Femoral Artery; Humans; Intermittent Claudication; Ischemia; Kaplan-Meier Estimate; Limb Salvage; Male; Metals; Middle Aged; Multivariate Analysis; Paclitaxel; Popliteal Artery; Proportional Hazards Models; Prosthesis Design; Prosthesis Failure; Recurrence; Retreatment; Retrospective Studies; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome; Vascular Patency | 2017 |
Local paclitaxel delivery in peripheral vascular disease.
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Humans; Paclitaxel; Secondary Prevention | 2008 |
Local paclitaxel delivery in peripheral vascular disease.
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Femoral Artery; Humans; Paclitaxel; Popliteal Artery; Secondary Prevention; Vascular Patency | 2008 |
Successful revascularization of re-stenosis of lower extremity arteries with localized delivery of paclitaxel.
Topics: Aged; Angiography; Angioplasty, Balloon; Arterial Occlusive Diseases; Atherectomy; Female; Humans; Leg; Male; Middle Aged; Paclitaxel; Recurrence; Stents; Ultrasonography, Interventional | 2008 |
Recalcitrant in-stent restenosis of the celiac trunk treated by drug-eluting stent.
Topics: Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Cardiovascular Agents; Celiac Artery; Chronic Disease; Constriction, Pathologic; Drug-Eluting Stents; Female; Humans; Ischemia; Magnetic Resonance Angiography; Mesenteric Vascular Occlusion; Metals; Paclitaxel; Prosthesis Design; Recurrence; Stents; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Invited commentary.
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Cardiovascular Agents; Constriction, Pathologic; Critical Illness; Drug-Eluting Stents; Humans; Ischemia; Lower Extremity; Metals; Paclitaxel; Popliteal Artery; Prospective Studies; Prosthesis Design; Secondary Prevention; Stents; Treatment Outcome | 2009 |
Drug-eluting tibial stents: objective patency determination.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Angioplasty, Balloon; Arterial Occlusive Diseases; Cardiovascular Agents; Constriction, Pathologic; Drug-Eluting Stents; Female; Humans; Ischemia; Life Tables; Limb Salvage; Male; Middle Aged; Minnesota; Paclitaxel; Platelet Aggregation Inhibitors; Prosthesis Design; Radiography; Recurrence; Reoperation; Retrospective Studies; Severity of Illness Index; Tibial Arteries; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Duplex; Vascular Patency | 2010 |
Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study.
Topics: Aged; Alloys; Arterial Occlusive Diseases; Canada; Cardiovascular Agents; Constriction, Pathologic; Disease-Free Survival; Drug-Eluting Stents; Endovascular Procedures; Europe; Female; Femoral Artery; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Popliteal Artery; Prospective Studies; Prosthesis Design; Recovery of Function; Recurrence; Republic of Korea; Severity of Illness Index; Time Factors; Treatment Outcome; Vascular Patency | 2011 |
A new paclitaxel-eluting balloon for angioplasty of femoropopliteal obstructions: acute and midterm results.
Topics: Adult; Aged; Aged, 80 and over; Alloys; Angioplasty, Balloon; Ankle Brachial Index; Arterial Occlusive Diseases; Cardiovascular Agents; Coated Materials, Biocompatible; Constriction, Pathologic; Drug Delivery Systems; Equipment Design; Female; Femoral Artery; Humans; Italy; Male; Middle Aged; Paclitaxel; Popliteal Artery; Prospective Studies; Prosthesis Design; Recurrence; Registries; Stents; Time Factors; Treatment Outcome | 2011 |
Treatment paradigms for the superficial femoral artery: are they a-changin?
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Cardiovascular Agents; Catheters; Coated Materials, Biocompatible; Female; Femoral Artery; Humans; Male; Paclitaxel; Popliteal Artery | 2012 |
Clinical evaluation of a paclitaxel-eluting balloon for treatment of femoropopliteal arterial disease: 12-month results from a multicenter Italian registry.
Topics: Aged; Angioplasty, Balloon; Ankle Brachial Index; Arterial Occlusive Diseases; Cardiovascular Agents; Catheters; Chi-Square Distribution; Coated Materials, Biocompatible; Constriction, Pathologic; Female; Femoral Artery; Humans; Italy; Kaplan-Meier Estimate; Linear Models; Male; Middle Aged; Paclitaxel; Popliteal Artery; Prospective Studies; Quality of Life; Recovery of Function; Recurrence; Registries; Severity of Illness Index; Time Factors; Treatment Outcome; Vascular Patency; Walking | 2012 |
Drug-eluting balloons: are they the magic bullet?
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Cardiovascular Agents; Drug Carriers; Female; Femoral Artery; Humans; Lower Extremity; Male; Paclitaxel; Popliteal Artery; Vascular Access Devices | 2012 |
A budget impact model for paclitaxel-eluting stent in femoropopliteal disease in France.
Topics: Arterial Occlusive Diseases; Atherosclerosis; Budgets; Drug-Eluting Stents; Femoral Artery; France; Health Care Costs; Humans; Models, Economic; Paclitaxel; Peripheral Vascular Diseases; Popliteal Artery | 2013 |
Inhibition of vascular endothelial growth factor-mediated neointima progression with angiostatin or paclitaxel.
Topics: Analysis of Variance; Angiogenesis Inhibitors; Angiostatins; Animals; Arterial Occlusive Diseases; Endothelial Growth Factors; Femoral Artery; Immunoenzyme Techniques; Injections, Intramuscular; Ischemia; Lymphokines; Male; Neovascularization, Physiologic; Paclitaxel; Peptide Fragments; Plasminogen; Rabbits; Tunica Intima; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
Vertebral artery stenting utilizing distal embolic protection with filter wire and a drug-eluting Taxus stent.
Topics: Angiography; Arterial Occlusive Diseases; Drug Delivery Systems; Embolism; Fluoroscopy; Humans; Male; Middle Aged; Paclitaxel; Stents; Tomography, X-Ray Computed; Vertebral Artery | 2006 |
Biological treatment of vein grafts and stents in lower-extremity arterial reconstruction.
Topics: Arterial Occlusive Diseases; Blood Vessel Prosthesis Implantation; Drug-Eluting Stents; Graft Occlusion, Vascular; Humans; Hyperplasia; Leg; Oligonucleotides; Paclitaxel; Radiography; Tunica Intima; Vascular Patency | 2007 |